In 43 samples, mutations in KRAS (n=11; 11/43= 26%), BRAF (n=1; 1/43 = 2%), EGFR (n=6; 6/43 = 14%) and NRAS (n=1; 1/43 = 2%) were detected using iPLEX HS.